Cargando…
PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm
BACKGROUND: Primary tracheobronchial neoplasm is rare yet poses a serious threat to life. Due to its low incidence, the immune microenvironment of such tumors remained unclear. This study aimed to clarify the expression of programmed death-ligand 1 (PD-L1) and infiltration of immune cells in primary...
Autores principales: | Zheng, Kai-Fu, Liu, Yu-Jian, Ma, Nan, Xiong, Yan-Lu, Tang, Xi-Yang, Zhang, Qian, Luo, Zhong-Lin, Tian, Huan-Huan, Hofman, Paul, Ichiki, Yoshinobu, Metro, Giulio, Tachihara, Motoko, Gong, Li, Li, Xiao-Fei, Zhao, Jin-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743529/ https://www.ncbi.nlm.nih.gov/pubmed/35070765 http://dx.doi.org/10.21037/tlcr-21-958 |
Ejemplares similares
-
PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms
por: Higuchi, Rumi, et al.
Publicado: (2019) -
Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system
por: Bai, Shuai, et al.
Publicado: (2021) -
Tracheobronchial nebulizer DIVO™
por: Kurnosov, Nikolay Efimovich, et al.
Publicado: (2015) -
Iatrogenic tracheobronchial rupture
por: Paraschiv, M
Publicado: (2014) -
Primary tracheobronchial amyloidosis
por: Torres, Pedro Paulo Teixeira e Silva, et al.
Publicado: (2017)